-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE - PHASE I/II TRIAL CONDUCTED UNDER FDA OVERSIGHT IN U.S. AND ISRAEL

Reuters·06/22/2026 12:07:00

Please log in to view news